HK1149553A1 - Amide compounds as boosters of antivirals - Google Patents

Amide compounds as boosters of antivirals

Info

Publication number
HK1149553A1
HK1149553A1 HK11103719.1A HK11103719A HK1149553A1 HK 1149553 A1 HK1149553 A1 HK 1149553A1 HK 11103719 A HK11103719 A HK 11103719A HK 1149553 A1 HK1149553 A1 HK 1149553A1
Authority
HK
Hong Kong
Prior art keywords
antivirals
boosters
amide compounds
amide
compounds
Prior art date
Application number
HK11103719.1A
Other languages
English (en)
Inventor
Tim Hugo Maria Jonckers
Wim Bert Griet Schepens
Geerwin Yvonne Paul Haché
Beate Sabine Hallenberger
Jennifer Chiyomi Sasaki
Judith Eva Baumeister
Klooster Gerben Albert Eleutherius Van T
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39386111&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1149553(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of HK1149553A1 publication Critical patent/HK1149553A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
HK11103719.1A 2007-12-06 2011-04-13 Amide compounds as boosters of antivirals HK1149553A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07122468 2007-12-06
PCT/EP2008/066847 WO2009071650A2 (en) 2007-12-06 2008-12-05 Amide compounds as boosters of antivirals

Publications (1)

Publication Number Publication Date
HK1149553A1 true HK1149553A1 (en) 2011-10-07

Family

ID=39386111

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11103719.1A HK1149553A1 (en) 2007-12-06 2011-04-13 Amide compounds as boosters of antivirals

Country Status (24)

Country Link
US (1) US8350048B2 (xx)
EP (1) EP2235008B1 (xx)
JP (1) JP5509092B2 (xx)
KR (1) KR101624675B1 (xx)
CN (1) CN101878210B (xx)
AP (1) AP2804A (xx)
AR (1) AR069595A1 (xx)
AU (1) AU2008333165B2 (xx)
BR (1) BRPI0821021A2 (xx)
CA (1) CA2706155C (xx)
CL (1) CL2008003639A1 (xx)
EA (1) EA019616B1 (xx)
HK (1) HK1149553A1 (xx)
IL (1) IL205489A (xx)
MX (1) MX2010006166A (xx)
MY (1) MY151005A (xx)
NZ (1) NZ585652A (xx)
PA (1) PA8806801A1 (xx)
PE (1) PE20091263A1 (xx)
TW (1) TWI438202B (xx)
UA (1) UA103013C2 (xx)
UY (1) UY31513A1 (xx)
WO (1) WO2009071650A2 (xx)
ZA (1) ZA201004025B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009301131B2 (en) * 2008-10-07 2014-03-27 Janssen Sciences Ireland Uc New amide compounds as boosters of antivirals
US20120172368A1 (en) * 2009-09-03 2012-07-05 Koen Vandyck Bis-Benzimidazole Derivatives
US8759535B2 (en) 2010-02-18 2014-06-24 High Point Pharmaceuticals, Llc Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
CA2833006A1 (en) * 2011-04-22 2012-10-26 Merck Sharp & Dohme Corp. Taste-masked formulations of raltegravir
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug
CN104000824B (zh) * 2014-05-28 2016-07-06 中山大学 苯并五元杂环类化合物在制备抗hiv-1病毒药物中的应用
WO2016089648A1 (en) 2014-12-01 2016-06-09 Vtv Therapeutics Llc Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
CN105985356B (zh) * 2015-02-05 2018-06-22 四川大学 咪唑[2,1-b]噻唑衍生物及其制备方法和用途
AU2016375634B2 (en) 2015-12-22 2021-03-25 Kancera Ab Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity
AR114136A1 (es) 2017-10-10 2020-07-29 Hoffmann La Roche Compuestos heterocíclicos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037157A (en) * 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
AR037797A1 (es) 2001-12-12 2004-12-01 Tibotec Pharm Ltd Combinacion de inhibidores de proteasa dependientes del citocromo p450
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
CN101445493A (zh) * 2002-08-02 2009-06-03 泰博特克药品有限公司 广谱2-氨基-苯并噻唑磺酰胺类hiv蛋白酶抑制剂
AR053845A1 (es) * 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
WO2008022345A2 (en) * 2006-08-18 2008-02-21 Sequoia Pharmaceuticals, Inc. Compositions and methods for inhibiting cytochrome p450

Also Published As

Publication number Publication date
EA201070691A1 (ru) 2010-10-29
AU2008333165B2 (en) 2013-04-11
BRPI0821021A2 (pt) 2015-06-16
MY151005A (en) 2014-03-31
KR101624675B1 (ko) 2016-05-27
NZ585652A (en) 2011-10-28
CL2008003639A1 (es) 2010-01-15
IL205489A (en) 2016-09-29
AR069595A1 (es) 2010-02-03
AP2804A (en) 2013-11-30
EP2235008B1 (en) 2016-03-16
PA8806801A1 (es) 2009-07-23
TWI438202B (zh) 2014-05-21
KR20100092489A (ko) 2010-08-20
MX2010006166A (es) 2010-10-05
WO2009071650A2 (en) 2009-06-11
EA019616B1 (ru) 2014-05-30
CN101878210A (zh) 2010-11-03
WO2009071650A3 (en) 2009-09-11
AP2010005285A0 (en) 2010-06-30
TW200938540A (en) 2009-09-16
CA2706155C (en) 2016-07-19
ZA201004025B (en) 2011-12-28
UA103013C2 (uk) 2013-09-10
JP2011506291A (ja) 2011-03-03
EP2235008A2 (en) 2010-10-06
PE20091263A1 (es) 2009-08-14
US8350048B2 (en) 2013-01-08
IL205489A0 (en) 2010-12-30
US20100305073A1 (en) 2010-12-02
UY31513A1 (es) 2009-07-17
CA2706155A1 (en) 2009-06-11
CN101878210B (zh) 2013-07-17
JP5509092B2 (ja) 2014-06-04
AU2008333165A1 (en) 2009-06-11

Similar Documents

Publication Publication Date Title
HK1149553A1 (en) Amide compounds as boosters of antivirals
HK1125640A1 (en) Synthesis of acylaminoalkenylene amides useful as substance p antagonists
ZA201007686B (en) Amide compound
EP2298731A4 (en) AMIDE COMPOUND
EP2044055A4 (en) amide compounds
EP2172447A4 (en) amide
IL204970A0 (en) Amide compound
GB0806536D0 (en) Novel compounds
ZA201100123B (en) Bromine-facilitated synthesis of fluoro-sulfur compounds
GB0804592D0 (en) Novel compounds
GB0618703D0 (en) Synthesis of leikotriene compounds
IL208868A0 (en) Processes for the preparation of amides
EP2370440A4 (en) NEW COMPOUNDS
GB0804326D0 (en) Novel compounds
ZA201102553B (en) New amide compounds as boosters of antivirals
GB0800411D0 (en) Novel compounds
ZA200807790B (en) Synthesis of acylaminoalkenylene amides useful as substance P antagonists
GB0720507D0 (en) Amide addition reaction
ZA201101308B (en) Improved synthesis of hexahydrodibenzopyranones
GB0811131D0 (en) Novel compounds 336
GB0803103D0 (en) Novel compounds 3
GB0800839D0 (en) Novel compounds
GB0802677D0 (en) Novel compounds
GB0803212D0 (en) Novel compounds
GB0803306D0 (en) Novel compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181203